Canada · Delayed Price · Currency is CAD Westport Fuel Systems Earnings Call Transcripts
Fiscal Year 2026
-
Cespira and High Pressure Controls segments delivered strong year-over-year revenue growth, with Cespira's net loss narrowing significantly and gross margin improving. Expansion into new markets and continued operational execution position the business for further growth.
Fiscal Year 2025
-
Revenue grew 28% in Q4 2025, driven by HPDI adoption, while full-year revenue fell due to the end of a transitional agreement. Cash position strengthened to $27.2 million, debt reduced, and margin recovery is expected as new facilities ramp up.
-
Q3 2025 saw revenue decline due to the light-duty divestiture, but gross margin improved and Sospira delivered 19% revenue growth. Cash position strengthened, manufacturing is shifting to Canada and China, and new CNG solutions target North America.
-
Divestiture of the light-duty segment sharpened strategic focus, with Sospira and high-pressure controls driving growth. Revenue from continuing operations declined, but cost reductions improved adjusted EBITDA. Ongoing Sospira funding and hydrogen market shifts present both opportunities and risks.
-
Shareholders elected six directors, reappointed KPMG as auditors, and approved the executive compensation approach. The sale of Westport Fuel Systems Italia S.r.l. was authorized, with future growth focused on high pressure controls and the Cespira HPDI joint venture.
-
Q1 2025 saw improved profitability with a net loss reduction, higher gross margins, and positive operating income, despite a revenue dip from the heavy-duty OEM transition to Sospira. The light-duty divestiture is set to close in Q2, strengthening liquidity and focusing growth on HPDI and high-pressure systems.
Fiscal Year 2024
-
Announced sale of the light-duty business for $75.1 million to focus on HPDI and high-pressure controls, improving margins and reducing adjusted EBITDA loss year-over-year. Cash flow from operations turned positive, but liquidity remains a concern until the transaction closes.
-
Q3 2024 saw improved gross margins and a narrowed adjusted EBITDA loss, driven by cost reductions and strong light-duty segment performance, despite a revenue decline from the Cespira JV transition. Inventory is expected to normalize by year-end, and restructuring efforts will continue into 2025.
-
Q2 2024 featured improved margins and a narrowed EBITDA loss, driven by cost reductions and the HPDI JV launch with Volvo. Revenue dipped 2% year-over-year, but gross margin rose to 21%. Management expects further margin gains and cost savings as inventory issues resolve and new growth opportunities emerge.
-
The meeting confirmed the election of directors, auditor appointment, and approval of executive compensation. Strategic priorities include accelerating the HPDI joint venture with Volvo and advancing hydrogen solutions, with a focus on operational excellence and market expansion.